EncapX® on stage at World Vaccine Congress Europe 2026

Biotech One exhibited at World Vaccine Congress Europe 2026 at the RAI Amsterdam, in the Start-up Zone, booth SU3. One of the company’s posts placed the congress on 19-21 October. Another invitation covered 20 and 21 October.

Dr Elissandro Klein, R&D Project Manager, spoke on Wednesday 21 October from 11:30 to 11:40 am, on the Expo Stage in the Biopharma Showcases. The talk was titled “Redefining Nanocarrier Manufacturing with Scalable Continuous scCO₂ Processing for Advanced Vaccine Delivery”.

He presented recent work on continuous nano-encapsulation with supercritical CO₂. The aim stated by the company is to bridge R&D formulation and industrial manufacturing of liposomes and LNPs: continuous production, precise and reproducible particle size, fewer clogging risks, and no toxic solvents. The same post noted that the congress came days after the COSMETIC 360 Award in the Industry & Process category.

Biotech One thanked Prof. Elisabeth Badens and the scientific team. The booth was open to vaccine developers, biotech companies, pharmaceutical manufacturers and CDMOs, on formulation, RNA delivery, process optimisation and industrial scale-up.